-

07:13:43 PM

UPC Stock News

UPC - Universe Pharmaceuticals INC

12/21/22 8:00 AM

Nasdaq : UPC

covid-19low float

Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that six varieties of the Company’s products were included in the First Edition of Catalogue of Medicine for

RHEA-AI

neutral

11/14/22 8:00 AM

Nasdaq : UPC

low float

Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Listing Qualifications

RHEA-AI

neutral

08/16/22 8:00 AM

Nasdaq : UPC

earningslow float

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022

Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2022 ended March 31, 2022.Mr. Gang Lai, Chairman and

RHEA-AI

neutral

07/19/22 6:00 AM

Nasdaq : UPC

low float

Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC

RHEA-AI

neutral

03/30/22 8:00 AM

Nasdaq : UPC

partnershiplow float

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Lian-Ou Health

RHEA-AI

very positive

03/22/22 8:00 AM

Nasdaq : UPC

low float

Universe Pharmaceuticals INC Authorized as The International Branch of National Engineering Technology Research Center

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company has been authorized as an International Branch (the “Branch”) of the National Engineering

RHEA-AI

neutral

01/31/22 8:00 AM

Nasdaq : UPC

earningslow float

Universe Pharmaceuticals INC Reports Fiscal Year 2021 Financial Results

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its financial results for the fiscal year ended September 30, 2021. Mr. Gang Lai, Chairman and CEO of Universe

RHEA-AI

neutral

01/04/22 8:00 AM

Nasdaq : UPC

low float

Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Traditional Chinese Medicine

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province

RHEA-AI

very positive

12/29/21 8:00 AM

Nasdaq : UPC

low float

Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company had entered into a strategic cooperation agreement (the “Agreement”) with Jinggangshan

RHEA-AI

very positive

12/15/21 4:30 PM

Nasdaq : UPC

managementlow float

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer

Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company appointed Mr. Baochang Liu as its Chief Operating Officer, effective December 1, 2021. Mr.

RHEA-AI

neutral

UPC Data

IndustryPharmaceutical Preparation Manufacturing
Websitewww.universe-pharmacy.com/
Security nameUniverse Pharmaceuticals INC
Issue typecs
SectorManufacturing
Sic code2834
Employees2021

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a pharmaceutical producer and distributor in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process and to promote their general well-being. The Company also distributes and sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold in 30 provinces of China.